ABC-transporters expressed on endothelial cell membranes efflux anti-HIV drugs

Aug 26, 2008

Researchers at Tulane University Medical Center in New Orleans (USA) have discovered that drug-efflux pumps, belonging to the ATP-binding cassette (ABC) transporter family, are constitutively expressed on vascular endothelial cells. Transcripts for several different ABC-transporters, e.g. MDR-1 (P-gp) and MRPs, were detected in endothelial cells, obtained from brain, aortic artery, pulmonary artery, dermal microvessels and umbilical veins.

The ABC-transporter mediated efflux mechanisms decreased intracellular concentrations of the anti-HIV drugs, saquinavir, an HIV protease inhibitor (HPI) and zidovudine, a nucleoside reverse transcriptase inhibitor (NRTI), which are critical components of highly active antiretroviral therapy (HAART) against HIV. Inhibition of ABC-transporters, by using verapamil or MK-571, was shown to increase the intracellular retention of these anti-HIV agents.

The MRP transporters were found to play a more dominant role in drug-efflux from endothelial cells. Pre-incubation of cells with the MRP-inhibitor, MK-571 significantly enhanced the intracellular levels of anti-HIV drugs. This study, entitled 'MRP (ABCC) transporters-mediated efflux of anti-HIV drugs, saquinavir and zidovudine, from human endothelial cells,' will be published in the September 2008 issue of Experimental Biology and Medicine.

These investigations led by Dr. Debasis Mondal, an assistant professor of Pharmacology, and co-authored by Mr. Mark Eilers and Dr. Upal Roy, demonstrated the significance of blocking MRP-transporters on endothelial barriers of blood vessels, in order to increase the pharmacokinetic efficacy of both HPIs and NRTIs. Drug-efflux pumps expressed on the blood-brain-barrier (BBB) were previously known to decrease drug entry into the central nervous system (CNS), however, this is the first evidence that endothelial cells from other organs express functional ABC-transporters, as well. The functional expression of MRPs on vascular endothelial barriers implicates their crucial role in facilitating the persistence of sub-endothelial HIV reservoirs.

"Although we have a significant armament of therapeutic agents against HIV, factors that dictate the pharmacokinetics of anti-HIV drugs need to be accounted for in order to have HAART efficacy in sequestered viral reservoirs. Several P-gp inhibitors are currently under clinical trial, however, very little is being done to target the MRP-transporters. Our studies using the anti-HIV drugs, saquinavir and zidovudine, clearly implicated that inhibition of MRPs, rather than P-gp, would be a more beneficial approach to facilitate the entry of HAART drugs into the sub-endothelial reservoirs of HIV, especially within the brain. Unpublished findings from our laboratory suggest that, similar to MK-571, other leukotriene receptor antagonists, e.g. montelukast (SingulairTM) and zafirlukast (AccolateTM) can suppress MRP-mediated efflux of these anti-HIV drugs, as well. We believe that adjunct therapy with these clinically approved MRP inhibitors may improve HAART efficacy in HIV-positive patients, deter the selection of drug resistance and delay the progression of AIDS." Dr. Steve Goodman, Editor-in-Chief of Experimental Biology and Medicine said "this study by Dr. Mondal and colleagues has crucial implications in the persistence of sub-endothelial HIV reservoirs and will be important to the development of future therapies".

Source: Society for Experimental Biology and Medicine

Explore further: Preventing one case of HIV saves over $225K, study shows

add to favorites email to friend print save as pdf

Related Stories

New research signals big future for quantum radar

39 minutes ago

A prototype quantum radar that has the potential to detect objects which are invisible to conventional systems has been developed by an international research team led by a quantum information scientist at the University ...

Living in the genetic comfort zone

2 hours ago

The information encoded in the DNA of an organism is not sufficient to determine the expression pattern of genes. This fact has been known even before the discovery of epigenetics, which refers to external ...

'Bright spot' on Ceres has dimmer companion

3 hours ago

Dwarf planet Ceres continues to puzzle scientists as NASA's Dawn spacecraft gets closer to being captured into orbit around the object. The latest images from Dawn, taken nearly 29,000 miles (46,000 kilometers) ...

Key facts on US 'open Internet' regulation

3 hours ago

A landmark ruling by the US Federal Communications Commission seeks to enshrine the notion of an "open Internet," or "net neutrality." Here are key points:

Recommended for you

Preventing one case of HIV saves over $225K, study shows

Feb 27, 2015

How much money would be saved if one high-risk person was prevented from contracting HIV in the United States? A new study led by a researcher at Weill Cornell Medical College and published online Feb. 24 in Medical Care, answer ...

Research captures transient details of HIV genome packaging

Feb 27, 2015

Once HIV-1 has hijacked a host cell to make copies of its own RNA genome and viral proteins, it must assemble these components into new virus particles. The orchestration of this intricate assembly process falls to a viral ...

Could an HIV drug beat strep throat, flesh-eating bacteria?

Feb 25, 2015

With antibiotic resistance on the rise, scientists are looking for innovative ways to combat bacterial infections. The pathogen that causes conditions from strep throat to flesh-eating disease is among them, but scientists ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.